Document Detail

Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion.
MedLine Citation:
PMID:  15334879     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: Plasma brain natriuretic peptide (BNP) concentration is higher during atrial fibrillation (Af) than sinus rhythm, based on studies of electrical defibrillation treatment of patients with chronic Af. However, the change in paroxysmal atrial fibrillation (PAf) is not well known. This study investigated such changes and the relationship between BNP and Af. METHODS: BNP levels were successfully measured at three time points: before Af attack, during Af attack, and after (spontaneous or pharmacological) termination of 68 consecutive Af attacks in 35 outpatients with PAf (23 men, 12 women, mean age 70.4 +/- 9.6 years). BNP was measured by immunoradiometric assay. RESULTS: BNP (median[quartiles]) during PAf was increased by 66[25, 120] pg/ml (2.4-fold) compared to during sinus rhythm (p < 0.0001), and fell to the former level after return to sinus rhythm (before attack = 39[18, 70], during attack = 102[52, 205], after attack = 35[20, 67]). BNP increased in 55 (81%) of 68 attacks, did not change (within +/- 20 pg/ml) in 11 (16%), and decreased in 2 (3%). BNP was already elevated immediately (within 4 hr) after onset of Af, and BNP elevation (delta BNP) showed no significant relationship with the time elapsed after onset. During the Af attack, 41% of PAf patients were asymptomatic although BNP increased significantly. CONCLUSIONS: These results suggest that elevated amounts of BNP during Af are released from secretory granules in the atrium, and BNP elevation of unknown cause may be attributed to the presence of asymptomatic Af. Cardiac function evaluation using BNP during Af requires special consideration, unlike during sinus rhythm, even in patients with PAf or chronic Af, because BNP during Af is the sum of the BNP values from the ventricle (reflecting left ventricular function) and the atrium (due to Af).
Keizo Tsuchida; Kazuhiko Tanabe
Related Documents :
11501959 - Risk predictors of paroxysmal atrial fibrillation following aortic valve replacement.
17336879 - Atrial fibrosis and the mechanisms of atrial fibrillation.
23147439 - Long-term patient benefit with biodegradable polymer biolimus eluting stent.
1998339 - Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary...
15699259 - Atrial tachycardia remodeling of pulmonary vein cardiomyocytes: comparison with left at...
11839889 - Innovative endovascular defibrillator lead use in superior vena cava obstruction.
21116069 - A decade of percutaneous septal ablation in hypertrophic cardiomyopathy.
21186109 - Effect of bariatric surgery on peripheral flow-mediated dilation and coronary microvasc...
10639539 - Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular even...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiology     Volume:  44     ISSN:  0914-5087     ISO Abbreviation:  J Cardiol     Publication Date:  2004 Jul 
Date Detail:
Created Date:  2004-08-31     Completed Date:  2004-09-28     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8804703     Medline TA:  J Cardiol     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  1-11     Citation Subset:  IM    
Tsuchida Clinic of Internal and Cardiovascular Medicine, Nagaoka, Niigata.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Atrial Fibrillation / blood*,  physiopathology,  therapy
Electric Countershock
Immunoradiometric Assay
Middle Aged
Natriuretic Peptide, Brain / blood*
Reg. No./Substance:
114471-18-0/Natriuretic Peptide, Brain

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Communication and the patient/physician relationship: a phenomenological inquiry.
Next Document:  Effect of short-term administration of high dose L-arginine on restenosis after percutaneous translu...